Affordable Access

deepdyve-link
Publisher Website

Identification of patients with high-risk stage II colon cancer for adjuvant therapy.

Authors
  • Quah, Hak-Mien
  • Chou, Joanne F
  • Gonen, Mithat
  • Shia, Jinru
  • Schrag, Deborah
  • Landmann, Ron G
  • Guillem, José G
  • Paty, Philip B
  • Temple, Larissa K
  • Wong, W Douglas
  • Weiser, Martin R
Type
Published Article
Journal
Diseases of the Colon & Rectum
Publisher
Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins
Publication Date
May 01, 2008
Volume
51
Issue
5
Pages
503–507
Identifiers
DOI: 10.1007/s10350-008-9246-z
PMID: 18322753
Source
Medline
License
Unknown

Abstract

Patients with Stage II colon cancer generally have an excellent prognosis. However, the presence of multiple adverse prognostic factors identifies a high-risk subgroup. Use of commonly reported clinicopathologic features accurately stratifies Stage II colon cancer by disease-specific survival. Those identified as high-risk patients can be considered for adjuvant chemotherapy and/or enrollment in investigational trials.

Report this publication

Statistics

Seen <100 times